News

Filter

Current filters:

ChondroCelectOncology

101 to 110 of 96128 results

Chugai launches ALK inhibitor Alecensa in Japan

Chugai launches ALK inhibitor Alecensa in Japan

07-09-2014

Japanese drugmaker Chugai Pharmaceutical said on Friday that it has launched the ALK inhibitor Alecensa…

AlecensaalectinibChugai PharmaceuticalJapanMarkets & MarketingOncologyPharmaceuticalRoche

Depomed wins in law suit seeking FDA orphan drug exclusivity for Gralise

Depomed wins in law suit seeking FDA orphan drug exclusivity for Gralise

07-09-2014

US specialty drugmaker Depomed says that Judge Kentaji Brown Jackson of the federal district court for…

DepomedGraliseLegalNeurologicalPharmaceuticalRare diseasesUSA

Eisai divests US Zonegran rights to Concordia

Eisai divests US Zonegran rights to Concordia

07-09-2014

Japanese drugmaker Eisai (TYO: 4523) says its US subsidiary has entered into an agreement to divest its…

BiotechnologyConcordia PharmaceuticalsEisaiMergers & AcquisitionsNeurologicalUSAZonegran

Novel vaccine cuts recurrence in HER2 positive breast cancer patients

Novel vaccine cuts recurrence in HER2 positive breast cancer patients

07-09-2014

A new breast cancer vaccine candidate, GP2, provides further evidence of the potential of immunotherapy…

BiotechnologyGalena BioPharmaOncologyResearch

Soligenix acquires Ph III-ready oncology clinical program

Soligenix acquires Ph III-ready oncology clinical program

05-09-2014

US clinical-stage biopharma firm Soligenix has acquired a novel orphan drug candidate, known as SGX301…

BiotechnologyhypericinMergers & AcquisitionsOncologySGX301Soligenix

Mallinckrodt’s MNK-155 shows efficacy in Ph III acute pain trial

Mallinckrodt’s MNK-155 shows efficacy in Ph III acute pain trial

05-09-2014

US drugmaker Mallinckrodt reported that a Phase III efficacy trial of investigational MNK-155 met the…

AcuformDepomedMallinckrodtMNK-155NeurologicalPharmaceuticalResearch

FDA accepts Actavis’ NDA for ceftazidime-avibactam

FDA accepts Actavis’ NDA for ceftazidime-avibactam

05-09-2014

Ireland-headquartered generic drugs major Actavis today confirmed that the US Food and Drug Administration…

ActavisAntibiotics and Infectious diseasesceftazidime-avibactamPharmaceuticalRegulationResearchUSA

FDA lifts partial clinical hold on OncoMed's ipafricept

05-09-2014

Shares of US biotech companies OncoMed Pharmaceuticals rose 5.6% to $17.68 on news that the US Food and…

BayerBiotechnologyipafriceptOncologyOncoMed PharmaceuticalsRegulationResearchUSA

Sellas Life Sciences gains WT1 cancer vaccine rights from Memorial Sloan Kettering

Sellas Life Sciences gains WT1 cancer vaccine rights from Memorial Sloan Kettering

05-09-2014

Swiss/Greek pharmaceutical and clinical research group Sellas Life Sciences Group has signed an exclusive…

GlobalLicensingOncologyPharmaceuticalSellas Life SciencesVaccines

101 to 110 of 96128 results

Back to top